The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Griffin Deborah A since 2018.
The trader's CIK number is 1719115.
At the time of the last reporting, Griffin Deborah A was the Chief Accounting Officer of Teva Pharmaceutical Industries Ltd. (stock ticker symbol TEVA).
Also see all insider trading activities at Teva Pharmaceutical Industries Ltd.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | TEVA | 0 | $0 | 9,858 | $108,103 | 9,858 | $0 |
| 2019 | TEVA | 0 | $0 | 8,379 | $118,559 | 8,379 | $0 |
| 2018 | TEVA | 0 | $0 | 5,044 | $106,718 | 5,437 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-03-17 | TEVA | Option Ex | 944 | .00 | 0 |
| 2020-03-17 | TEVA | Sale | 944 | 7.16 | 6,762 |
| 2020-03-04 | TEVA | Option Ex | 4,807 | .00 | 0 |
| 2020-03-04 | TEVA | Sale | 4,807 | 11.23 | 53,977 |
| 2020-03-03 | TEVA | Sale | 1,166 | 11.37 | 13,252 |
| 2020-03-02 | TEVA | Sale | 2,941 | 11.60 | 34,112 |
| 2020-03-03 | TEVA | Option Ex | 1,166 | .00 | 0 |
| 2020-03-02 | TEVA | Option Ex | 2,941 | .00 | 0 |
| 2019-09-18 | TEVA | Option Ex | 2,376 | .00 | 0 |
| 2019-09-18 | TEVA | Sale | 2,376 | 7.83 | 18,606 |
| 2019-03-17 | TEVA | Option Ex | 943 | .00 | 0 |
| 2019-03-18 | TEVA | Sale | 943 | 16.62 | 15,677 |
| 2019-03-12 | TEVA | Sale | 953 | 15.68 | 14,938 |
| 2019-03-12 | TEVA | Option Ex | 953 | .00 | 0 |
| 2019-03-02 | TEVA | Option Ex | 2,941 | .00 | 0 |
| 2019-03-03 | TEVA | Option Ex | 1,166 | .00 | 0 |
| 2019-03-04 | TEVA | Sale | 4,107 | 16.88 | 69,338 |
| 2018-09-18 | TEVA | Option Ex | 2,376 | .00 | 0 |
| 2018-09-18 | TEVA | Sale | 2,376 | 23.71 | 56,327 |
| 2018-03-19 | TEVA | Sale | 943 | 17.88 | 16,858 |
| 2018-03-17 | TEVA | Option Ex | 943 | .00 | 0 |
| 2018-03-12 | TEVA | Option Ex | 952 | .00 | 0 |
| 2018-03-12 | TEVA | Sale | 952 | 19.49 | 18,553 |
| 2018-03-03 | TEVA | Option Ex | 1,166 | .00 | 0 |
| 2018-03-05 | TEVA | Sale | 773 | 19.38 | 14,980 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Griffin Deborah A (Chief Accounting Officer of Teva Pharmaceutical Industries Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.